STOCKHOLM, March 14, 2023 /PRNewswire/ BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the U.S. Veterans Health Administration (VHA) is providing coverage
/PRNewswire/ BioArctic AB s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the U.S. Veterans Health Administration (VHA) is providing.
The Veterans Health Administration will pay for some beneficiaries to get a new Alzheimer s disease drug. Leqembi received FDA approval in January as a nonformulary drug. Patients who want to take the medication would have to request it, receive prior approval and meet stringent inclusion criteria.
/PRNewswire/ The Alzheimer s Association applauds the decision by the U.S. Veterans Health Administration (VHA) to provide coverage of the Food and Drug.
A new study by researchers at Washington University School of Medicine in St. Louis found that the quality of care for lung cancer in the U.S. varies widely. The findings show that high-quality care is associated with improved overall survival rates among patients with lung cancer.